ER 4 2.25 (Pramipexole Dihydrochloride Extended-Release 2.25 mg)
Pill with imprint ER 4 2.25 is White, Elliptical/Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 2.25 mg. It is supplied by Macleods Pharmaceuticals Limited.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ER 4 2.25
Pramipexole Dihydrochloride Extended-Release
- Imprint
- ER 4 2.25
- Strength
- 2.25 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Macleods Pharmaceuticals Limited
- National Drug Code (NDC)
- 33342-0211
- Inactive Ingredients
-
hypromelloses,
mannitol,
corn starch,
carbomer homopolymer type C,
magnesium stearate,
silicon dioxide
Note: Inactive ingredients may vary.
Related images for "ER 4 2.25"
More about pramipexole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (215)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.